EGFR and non-small cell lung carcinoma: It was found that the frequency of EGFR mutated NSCLC patients is 25.4% of all cases, with the highest number in Najd (central region), followed by non-Saudis and the least number was found to be in the southern region, while no other available researches in Saudi Arabia are present at the moment to compare with.